GlassScriptPhysician profile
Satish Govindaraj
NPI 1205871365
$39,457.80
in general payments reported to CMS, 2019-2025
17 companies · $5,215 in 2025
The $5,215 reported for 2025 was more than what 96% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $12K · 2020: $1,835 · 2021: $1,733 · 2022: $2,076 · 2023: $15K · 2024: $1,376 · 2025: $5,215.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Travel and Lodging: $5,309 · Food and Beverage: $5,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,275.00 |
| Travel and Lodging | $5,308.95 |
| Food and Beverage | $5,122.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurent Medical Limited | $19,271.44 | 2022-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Olympus Corporation of The Americas | $11,469.21 | 2019-2021 | |
| Stryker Corporation | $1,627.99 | 2019-2025 | Scopis Ent, Nasopore, Shaver System |
| Acclarent, INC | $1,442.28 | 2019-2023 | Trudi Nav Cable |
| Olympus Corporation | $1,062.50 | 2020 | |
| Medtronic, INC. | $980.19 | 2021-2025 | Stealthstation S8 Platform, Sinuva |
| Intersect Ent, INC. | $659.31 | 2019-2022 | |
| Genzyme Corporation | $652.41 | 2020-2025 | |
| Medtronic USA, INC. | $629.64 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $532.21 | 2022-2025 | Dupixent |
| Optinose US, INC. | $486.51 | 2019-2022 | |
| Integra Lifesciences Corporation | $322.23 | 2024-2025 | Trudi Probe, Inspira Air, Acclarent Aera |
| Aerin Medical INC. | $122.72 | 2021-2023 | |
| Arrinex, INC. | $100.24 | 2019 | |
| Spirair, INC. | $49.23 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $34.09 | 2025 | Nucala |
| Alk-Abello, INC | $15.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Satish Govindaraj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.